LncRNA BRE-AS1 interacts with miR-145-5p to regulate cancer cell proliferation and apoptosis in prostate carcinoma and has early diagnostic values

@article{Chen2019LncRNABI,
  title={LncRNA BRE-AS1 interacts with miR-145-5p to regulate cancer cell proliferation and apoptosis in prostate carcinoma and has early diagnostic values},
  author={Zhong-Jun Chen and Ming Zhen and Jiajie Zhou},
  journal={Bioscience Reports},
  year={2019},
  volume={39}
}
Long non-coding RNA (LncRNA) BRE-AS1 has recently proven to be a tumor suppressor in lung cancer. The present study aimed to investigate the involvement of lncRNA BRE-AS1 in prostate carcinoma (PC). In the present study we found that plasma BRE-AS1 and miR-145-5p were both down-regulated in PC patients than in healthy controls. Down-regulation of BRE-AS1 and miR-145-5p effectively distinguished early-stage PC patients from healthy controls. A significant and positive correlation between BRE-AS1… 

Figures from this paper

Long non-coding RNA BRE-AS1 inhibits the proliferation, migration, and invasion of cancer cells in triple-negative breast cancer and predicts patients’ survival by downregulating miR-21

BRE-AS1 may inhibit TNBC by downregulating miR-21, a recently identified tumor suppressor in non-small cell lung cancer, which is inversely correlated with unfavorable survival outcomes and RNA pull-down assay illustrated that BRE-as1 may sponge premature miR -21 to suppress it maturation.

LncRNA BRE-AS1 acts as a tumor suppressor factor in bladder cancer via mediating STAT3.

In vitro experiments demonstrated that over-expression of lncRNA BRE-AS1 inhibited BC cell proliferation but promoted cell apoptosis of EJ and T24 cells, which might provide a new sight for the understanding of BC progression and biotherapy.

PGM5-AS1 impairs miR-587-mediated GDF10 inhibition and abrogates progression of prostate cancer

PGM5-AS1 upregulates GDF10 gene expression by competitively binding to miR-587, thus inhibiting proliferation and accelerating apoptosis of PCa cells.

Long non-coding RNA LINC01116 acts as an oncogene in prostate cancer cells through regulation of miR-744-5p/UBE2L3 axis

This study suggested that lncRNA LINC01116 acted as an oncogene in prostate cancer and accelerated prostate cancer cell growth through regulating miR-744-5p/UBE2L3 axis.

LncRNA CASC9 regulates cell proliferation, apoptosis and cell cycle via sponging miR-145-5p in colon cancer cells

LncRNA CASC9 is an oncogene in CC cells through sponging miR-145-5p, which was down-regulated in CC tissues, especially in CC at advanced TNM stages.

LINC00908 negatively regulates microRNA-483-5p to increase TSPYL5 expression and inhibit the development of prostate cancer

Overall, LINC00908 could competitively bind to miR-483-5p to increase the expression of TSPYL5, thereby inhibiting the progression of PCa, and may serve as a novel target for the treatment ofPCa.

Circular RNA VANGL1 knockdown suppressed viability, promoted apoptosis, and increased doxorubicin sensitivity through targeting miR-145-5p to regulate SOX4 in bladder cancer cells

Circ_VANGL1 mediated cell viability, apoptosis, and doxorubicin sensitivity by regulating miR-145-5p/SOX4 axis in bladder cancer, providing a potential therapeutic target for bladder cancer therapy.

Molecular Landscape of LncRNAs in Prostate Cancer: A focus on pathways and therapeutic targets for intervention

The role of epigenetic alterations in prostate cancer development are emphasized here and lncRNAs were chosen for this purpose and their expression level and interaction with other signaling networks in prostate cancers progression were examined.

Comprehensive Analysis of Competitive Endogenous Rnas Network Associated With Hepatocellular Carcinoma

Novel insights are provided into the lncRNA-related ceRNA network in HCC and the MYLK-AS1 may be a candidate biomarker for molecular diagnosis and prognosis monitoring of HCC.

References

SHOWING 1-10 OF 29 REFERENCES

miR-145-5p inhibits the proliferation and migration of bladder cancer cells by targeting TAGLN2

The miR-145-5p appeared to regulate TAGLN2 in BC, and it also inhibited the cell proliferation and migration, which may provide new therapeutic implications for BC.

Overexpression of miR-145–5p Inhibits Proliferation of Prostate Cancer Cells and Reduces SOX2 Expression

It is proposed that miR-145–5p, being an important regulator of SOX2, carries a crucial role in PCa tumorigenesis.

miR-145-5p Inhibits Vascular Smooth Muscle Cells (VSMCs) Proliferation and Migration by Dysregulating the Transforming Growth Factor-β Signaling Cascade

It is demonstrated that miR-145-5p is downregulated in PDGF-mediated VSMCs in both time- and dose-dependent manners and is identified as a novel regulator of VSMC.

Epigenetic silencing of miR-145-5p contributes to brain metastasis

Comparison of primary lung tumors and their matched metastatic brain disseminations identified shared patterns of several microRNAs, including common down-regulation of miR-145-5p, which attributes pivotal roles in malignancy progression and in metastasis.

Aberrant miR‐145–5p/β‐catenin signal impairs osteocyte function in adolescent idiopathic scoliosis

This is the first study to demonstrate the effect of aberrant miRNA expression and its effect on osteocyte function in AIS, which may contribute to the low bone mass and insight into the development of circulating microRNAs as a bone quality biomarker or even a prognostic biomarker for AIS.

The hallmarks of cancer

Here, the cellular processes influenced by long ncRNAs to the hallmarks of cancer are linked and therefore, an ncRNA point-of-view on tumor biology is provided.

Non-coding RNAs in human disease

Dysregulation of these ncRNAs is being found to have relevance not only to tumorigenesis, but also to neurological, cardiovascular, developmental and other diseases, and there is great interest in therapeutic strategies to counteract these perturbations.